Core Insights - The Pulse of Crypto — Singapore 2025 survey indicates a growing maturity in Singapore's cryptocurrency market, with increased ownership and cautious allocations among retail investors [2][4][10] Group 1: Survey Findings - 61% of finance-forward Singaporeans reported holding cryptocurrency, indicating a shift from niche participation to mainstream retail finance [7][8] - The average self-reported portfolio allocation to crypto is between 6% and 12%, reflecting interest with a limited risk appetite [8] - Trust is the primary factor in exchange selection, with 65% of respondents prioritizing it over fees (42%) [8] Group 2: Education and Trust - The report emphasizes the need for targeted educational initiatives to close knowledge gaps and reduce reliance on social media for information [9] - Platforms are encouraged to enhance security, transparency, and regulatory compliance to build consumer confidence [9] Group 3: Growth Opportunities - The report outlines priorities for the financial and crypto ecosystem in Singapore, focusing on inclusive access, diversified participation, and responsible long-term allocation [9]

Core Insights - MiniLuxe Holding Corp. reported continued double-digit system-wide sales growth and 10 consecutive quarters of unit economic improvement [1][6] Financial Performance - For Q3 2025, total revenue reached $7.261 million, reflecting a 7% year-over-year increase, while year-to-date (YTD) revenue was $20.873 million, an 8% increase [5][6] - Gross profit for Q3 2025 was $3.105 million, a 6% increase from the previous year, maintaining a gross margin of 43% [5][6] - Adjusted EBITDA for Q3 2025 was ($912,000), showing a 2% improvement compared to the previous year [5][12] Sales Growth - System-wide sales growth was 11% year-over-year for Q3 2025, totaling $7.6 million, with net revenue growth of 7% to $7.3 million [6] - Year-to-date sales growth also stood at 11%, with system-wide revenue at $21.6 million and net revenue at $20.9 million [6] Unit Economics - The company has seen improvements in unit economics for 10 consecutive quarters, driven by a favorable service mix and labor efficiency [6] - Cash contribution on a 4-wall basis for the full company-owned fleet increased approximately 40% year-over-year [6] Team and Client Metrics - The company reported an 87% year-over-year retention rate of hourly team members, with over 50% of the team having more than 5 years of tenure [6] - MiniLuxe achieved a net promoter score (NPS) of over 85, indicating strong client loyalty, with around 80% of clients being repeat customers [6] Growth Strategy - MiniLuxe's strategy includes strengthening unit economics across its 24 studios and expanding growth through mergers and acquisitions (M&A) and franchise partnerships [4][6] - The company signed a new franchise operating partner for the Connecticut region, covering three new sites, and is actively evaluating M&A opportunities [6]

Core Insights - Scientific Industries, Inc. reported a 15% year-over-year increase in sales from its Torbal Division, contributing to a 52.2% rise in net revenues for Q3 2025 compared to Q3 2024 [1][6][8] - The company launched its first AI-powered feature for the VIVID WORKSTATION, enhancing pharmacy automation and compliance [1][4] - The financial results for the nine months ended September 30, 2025, showed a slight decline in total revenues, primarily due to decreased revenues from Bioprocessing Systems Operations [8][12] Business Highlights - The introduction of AI capabilities in the VIVID WORKSTATION is expected to redefine innovation in pharmacy automation, leading to cost efficiencies for customers [4] - The company achieved a 27% year-over-year sales increase for VIVID products [6] - The DOTS MPS Platform was enhanced with single-use nanoparticles for baffled flasks, indicating ongoing innovation in bioprocessing solutions [6] Financial Overview - For Q3 2025, net revenues increased by $69,600 to $1,404,000, driven by the Torbal Division's performance [6] - Gross profit for Q3 2025 was $638,600, resulting in a gross margin of 45.5%, down from 51.0% in the prior year [9][20] - Operating expenses decreased by $84,800 to $2,160,900 for Q3 2025, reflecting cost reductions in Bioprocessing Systems Operations [10] Income Statement Highlights - The company reported a net income of $3,994,400 for Q3 2025, compared to a net loss of $1,180,100 in Q3 2024 [12][20] - Earnings per share for Q3 2025 were $0.34, a significant improvement from a loss of $(0.11) per share in the same period last year [12][21] - Total other income for Q3 2025 was $5,526,900, primarily due to a gain on the sale of the Genie Division [11][20]

Core Viewpoint - Brookfield Infrastructure Corporation has initiated an "at the market" equity issuance program allowing for the sale of up to $400 million of class A exchangeable subordinate voting shares to enhance financial flexibility and support corporate activities [1][2][4]. Group 1: ATM Program Details - The ATM Program allows Brookfield Infrastructure Corporation to sell shares directly from treasury at prevailing market prices through various exchanges [2][6]. - The program is designed to be non-dilutive, maintaining the overall number of LP Units and BIPC Shares outstanding [5]. - The net proceeds from the ATM Program will be used for repurchases of LP Units under the normal course issuer bid program and for general corporate purposes [4][5]. Group 2: Regulatory and Legal Framework - The ATM Program is supported by a Distribution Agreement with Canadian and U.S. agents, and it complies with applicable securities laws [6][7]. - The program will terminate upon the earlier of the sale of all BIPC Shares, termination of the Distribution Agreement, or on February 28, 2027 [6]. Group 3: Company Overview - Brookfield Infrastructure is a global infrastructure company focused on high-quality, long-life assets across various sectors, generating stable cash flows [11][12]. - The company is part of Brookfield Asset Management, which manages over $1 trillion in assets [12].

Core Viewpoint - FibroBiologics, Inc. has successfully closed a registered direct offering, raising approximately $4 million through the issuance of common stock and pre-funded warrants, with a unique payment method involving gold coins [1][2][4]. Company Overview - FibroBiologics is a clinical-stage biotechnology company focused on developing therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, holding over 270 patents [1][10]. - The company is engaged in various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer [10]. Offering Details - The company issued 3,540,000 shares of common stock and pre-funded warrants to purchase 8,570,203 shares at a price of $0.3303 per share [1]. - The purchase price was paid with sovereign-issued .9999 fine gold coins valued at $4,069.18 per ounce [2]. - In a concurrent private placement, unregistered warrants were issued to purchase up to 12,110,203 shares of common stock, with an exercise price of $0.3303 per share [3]. Financial Implications - The gross proceeds from the offering were approximately $4 million, intended for general corporate purposes, including debt satisfaction [4]. - If the unregistered warrants are fully exercised for cash following stockholder approval, the company could receive an additional $4 million [4]. Regulatory Compliance - The shares and pre-funded warrants were offered under a shelf registration statement previously filed with the SEC [5]. - The unregistered warrants were offered in a private placement and have not been registered under the Securities Act [6].

Core Insights - Magnera reported a strong performance in the fourth quarter of 2025, achieving net sales of $839 million, a 51% increase compared to the same quarter in 2024, driven by the Glatfelter merger and favorable foreign currency changes [3][6][5] - The company aims to improve reported earnings by approximately 9% in 2026 through cost improvement and capacity optimization initiatives [2][14] - Magnera's adjusted EBITDA for the fiscal year 2025 was $354 million, reflecting a 26% increase from the previous year [3][5] Financial Performance - For the September quarter, net sales reached $839 million, with an operating income of $10 million, compared to a loss of $167 million in the same quarter of 2024 [3][5] - The fiscal year 2025 net sales totaled $3.2 billion, up from $2.2 billion in 2024, while operating income improved to $5 million from a loss of $141 million [3][5] - Adjusted EBITDA for the September quarter was $90 million, a 36% increase year-over-year, and for the fiscal year, it was $354 million, a 26% increase [3][5][7] Segment Performance - In the Americas segment, net sales increased by $122 million due to the Glatfelter merger, although this was partially offset by a $28 million decrease in selling prices and a 3% organic volume decline [8][9] - The Rest of World segment saw a net sales increase of $206 million, aided by the Glatfelter merger and favorable foreign currency impacts, despite a 4% organic volume decline [10] Cash Flow and Debt Management - Magnera achieved record cash flow with cash from operations of $96 million in the fourth quarter and a post-merger adjusted free cash flow of $126 million, representing a yield of over 30% [5][12] - The company is focused on reducing leverage, ending the fiscal year with a leverage ratio of 3.8x and total net debt of $1.647 billion [13][11] Future Guidance - For fiscal year 2026, Magnera projects adjusted EBITDA between $380 million and $410 million, and free cash flow between $90 million and $110 million [14][27]

Core Insights - Montage Gold Corp. has reported multiple high-grade intercepts from its ongoing exploration program at the Petit Yao target, indicating its potential as a significant satellite deposit near the Koné processing plant [2][5][7] Exploration Results - The Petit Yao target has shown continuity over a strike length of over 1.1 km and to a depth of 150 meters, with mineralization open in all directions [3][7] - Notable drill results include: - 6.0 meters at 7.26 g/t Au from 55 meters - 6.0 meters at 5.09 g/t Au from 59 meters - 5.0 meters at 5.12 g/t Au from 43 meters [7][8] Drilling Program - A total of 4,068 meters have been drilled in 2025, with plans for an additional 6,800 meters before year-end, focusing on the Petit Yao target [4][14] - The drilling program has been modified to prioritize the Petit Yao target due to its promising results [6][14] Geology and Mineralization - The Petit Yao target is located approximately 7 km from the Koné processing plant and is characterized by shear-hosted parallel quartz-pyrite ± tourmaline veining [9][12] - The mineralization is associated with specific lithologies, including Birimian fine-grained sediments and mafic volcanics [12] Metallurgical Testing - Preliminary metallurgical tests indicate high recoverable gold rates, with oxide material averaging approximately 98.7% recovery [20] Future Plans - The company aims to publish a maiden starter resource for Petit Yao upon completion of the ongoing drilling program, along with updates for other deposits [7][23]

Revenue and Network Growth Continues in Q3 2025TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the three and nine months ended September 30, 2025. The Company reported continued revenue growth in the third quarter of 2025, up 175% from Q3 2024, while cost of revenues were up only 55% during the same time period, maintainin ...

Provider of Smart City and Building Solutions Joins Itron Engage Channel Partner ProgramLIBERTY LAKE, Wash., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced that Connected Lighting Solutions (CLS) has joined the Itron Engage Sales Channel Partner Program in Australia. CLS, a subsidiary of the Beacon Lighting Group and a leading provider in intelligent street lighting systems, will support the deployment ...

Core Points - Galway Metals Inc. has entered into an agreement with Red Cloud Securities Inc. for a private placement aiming to raise up to C$10,000,000.55 through the sale of units and flow-through units [1][4] - The offering includes 3,703,704 units priced at C$0.54 each and 10,596,027 flow-through units priced at C$0.755 each [1][2] - The proceeds will be used for exploration of the Clarence Stream gold project and for general corporate purposes [4][5] Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, while each flow-through unit consists of one flow-through share and one-half of a warrant [2] - The warrants allow the holder to purchase one common share at C$0.80 within 36 months after the closing date [2] - An option is granted to Red Cloud to sell an additional C$1,500,000 in units and flow-through units prior to the closing [3] Regulatory and Closing Information - The offering is subject to regulatory approvals and is scheduled to close on December 10, 2025 [8] - The securities will be offered to purchasers in several Canadian provinces and may also be sold in offshore jurisdictions [6] Company Overview - Galway Metals is focused on advancing its 100%-owned Clarence Stream gold project in New Brunswick, which has a significant exploration potential [11] - The company also owns the Estrades project, a former high-grade polymetallic mine in Quebec [11] - The management team has a proven track record of creating shareholder value, having previously sold Galway Resources for US$340 million [11]